Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting

Author:

Cohn Iris123,Manshaei Roozbeh2,Liston Eriskay3,Okello John B. A.3,Khan Reem3,Curtis Meredith R.3,Krupski Abby J.1,Jobling Rebekah K.345,Kalbfleisch Kelsey34,Paton Tara A.6,Reuter Miriam S.3678,Hayeems Robin Z.910,Verstegen Ruud H. J.11112,Goldman Aaron13,Kim Raymond H.3414,Ito Shinya1212

Affiliation:

1. Division of Clinical Pharmacology and Toxicology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

2. Program in Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada

3. Cardiac Genome Clinic, Ted Rogers Centre for Heart Research, The Hospital for Sick Children, Toronto, Ontario, Canada

4. Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada

5. Genome Diagnostics, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada

6. The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada

7. Canada’s Genomic Enterprise (CGEn), The Hospital for Sick Children, Toronto, Ontario, Canada

8. Genetics and Genome Biology, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada

9. Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada

10. Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

11. Division of Rheumatology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada

12. Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada

13. DNALabs Canada Inc, Toronto, Ontario, Canada

14. Fred A. Litwin Family Centre in Genetic Medicine, University Health Network, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference48 articles.

1. Adverse drug reactions in children: pediatric pharmacy and drug safety.;Rieder;J Pediatr Pharmacol Ther,2019

2. Adverse drug reactions across the age continuum: epidemiology, diagnostic challenges, prevention, and treatments.;Rieder;J Clin Pharmacol,2018

3. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.;Dunnenberger;Annu Rev Pharmacol Toxicol,2015

4. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.;Hoffman;Am J Med Genet C Semin Med Genet,2014

5. Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.;Krebs;Hum Genomics,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3